Skip to main content
REMED CO.,LTD. logo

REMED CO.,LTD. — Investor Relations & Filings

Ticker · 302550 ISIN · KR7302550009 KO Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2026-03-19 Major Shareholding Noti…
Country KR South Korea
Listing KO 302550

About REMED CO.,LTD.

https://www.remed.kr/en/

REMED CO.,LTD. is a medical device company specializing in the research, development, and manufacturing of electronic medication, also known as electroceuticals. The company focuses on providing non-invasive treatment solutions for intractable brain diseases, rehabilitation, and pain management. Its core technologies include transcranial magnetic stimulation (TMS) for neural modulation, as well as advanced electromagnetic stimulation, shockwave, and laser therapies. REMED produces both complete medical systems and essential core components, positioning itself as a provider of differentiated solutions in the medical technology sector.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Financial Investment Services and Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements of major shareholders (the 'Report on Large Shareholding' or '5% Rule' report). This type of filing is categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2026-03-19 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 23rd fiscal year (2025) of REMED Co., Ltd. It contains comprehensive information including company overview, history, capital changes, business activities, product details, and production facilities. This is a standard annual regulatory filing in South Korea, which corresponds to the '10-K' (Annual Report) category in the provided classification system. FY 2025
2026-03-17 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It contains the auditor's opinion, financial statements (consolidated and separate), and key financial metrics for the fiscal year. While it provides financial data, it is a standard regulatory disclosure form used in the Korean market to announce the receipt and submission of the audit report, rather than the full, multi-page annual report document itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2025
2026-03-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (stock-backed loans) of the company's major shareholders and special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2026-03-12 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy) and contains detailed information regarding the upcoming Annual General Meeting (AGM) of the company 'Remed'. It includes the purpose of the meeting, voting procedures (electronic voting/proxy), and financial statements (balance sheet, income statement, etc.) as reference materials for shareholders. This is a standard proxy solicitation document used to request shareholder votes for an AGM.
2026-03-10 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for REMED Co., Ltd. It outlines the meeting agenda, including the approval of financial statements, election of directors, and other corporate governance matters. It also includes detailed information on voting procedures, electronic voting, and business reports. This document is a standard proxy statement/notice for an upcoming Annual General Meeting (AGM).
2026-03-10 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.